ATTENTION: NEWS AND STORY PRODUCERS
Weekly JAMA Feature for January 5
BENEFIT OF ANTIDEPRESSANT MEDICATION VARIES BASED ON THE SEVERITY OF DEPRESSION SYMPTOMS
JAMA RADIO REPORT
Each week, JAMA, the Journal of the American Medical Association produces a one-minute radio news package, and makes it available to stations free of charge at www.TheJAMAReport.org
Producers can download MP3 versions of the packages, and are free to edit the pieces and/or use the actualities as best suits their stations’ needs.
Each week, JAMA, the Journal of the American Medical Association produces a one-minute radio news package, and makes it available to stations free of charge at www.TheJAMAReport.org
Producers can download MP3 versions of the packages, and are free to edit the pieces and/or use the actualities as best suits their stations’ needs.
This week’s package has an embargo: 4pm(ET) Tuesday, January 5, 2010
Radio script (TRT APPROX. 1:00)
January 5, 2010
VO: DEPRESSION MAY AFFECT AS MANY AS ONE IN TEN ADULTS YEARLY AND IS CAUSED BY CHEMICAL IMBALANCES IN THE BRAIN. ANTIDEPRESSANT MEDICATIONS MAY BE USED TO HELP CORRECT THOSE IMBALANCES.
“What we found is that patients who are on the lower end of the severity, even on the sort of middle range of severity, the medications weren’t doing much more than the placebo was, for patients at the higher end of severity the medications had a very potent effect.”
VO: IN RESEARCH FEATURED THIS WEEK IN JAMA, JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, DOCTORAL CANDIDATE, JAY FOURNIER (FORN-YUR) AND DR. ROBERT DERUBEIS (DUH-RUE-BAHS), BOTH FROM THE UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA AND CO-AUTHORS ASSESSED DATA FROM SIX DIFFERENT RANDOMIZED STUDIES USING ANTIDEPRESSANTS VERSUS A PLACEBO ON 718 PATIENTS.
“It both highlights the importance of the medicines for those patients who are at the more severe ranges of depression but it also questions the importance of those same medicines for patients whose severity levels are moderate or less.”
VO: CATHERINE DOLF, THE JAMA REPORT.
Radio script (TRT APPROX. 1:00)
January 5, 2010
VO: DEPRESSION MAY AFFECT AS MANY AS ONE IN TEN ADULTS YEARLY AND IS CAUSED BY CHEMICAL IMBALANCES IN THE BRAIN. ANTIDEPRESSANT MEDICATIONS MAY BE USED TO HELP CORRECT THOSE IMBALANCES.
“What we found is that patients who are on the lower end of the severity, even on the sort of middle range of severity, the medications weren’t doing much more than the placebo was, for patients at the higher end of severity the medications had a very potent effect.”
VO: IN RESEARCH FEATURED THIS WEEK IN JAMA, JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, DOCTORAL CANDIDATE, JAY FOURNIER (FORN-YUR) AND DR. ROBERT DERUBEIS (DUH-RUE-BAHS), BOTH FROM THE UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA AND CO-AUTHORS ASSESSED DATA FROM SIX DIFFERENT RANDOMIZED STUDIES USING ANTIDEPRESSANTS VERSUS A PLACEBO ON 718 PATIENTS.
“It both highlights the importance of the medicines for those patients who are at the more severe ranges of depression but it also questions the importance of those same medicines for patients whose severity levels are moderate or less.”
VO: CATHERINE DOLF, THE JAMA REPORT.